Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases


Introduction-Breast cancer is the most common cancer and leading cause of death in women. In India, its incidence is rapidly rising over last few decades. Present study is aimed to study the pattern of expression of hormonal receptors and Her-2/neu in invasive breast carcinoma and to correlate estrogen receptor (ER), progesterone receptor (PR) and Her-2/neu expressions with various clinicopathological parameters. Material and methods: The present study was carried out in Department of Pathology, S.C.B. Medical College, Cuttack in the year 2013 taking consecutive 100 cases. Routine H&E staining for histological diagnosis and IHC analysis for ER, PR and Her 2/neu was carried out in all 100 cases of breast malignancies. Results: 99% of cases are invasive breast carcinoma, not otherwise specify (IDC-NOS). The age ranges from 23 years to 72 years. Majority of tumors are of grade 2 (70%) followed by grade 3 (30%). ER PR and Her-2/neu expression are seen in 45%, 35% and 30% respectively. Triple negative cases comprise 35%. Higher number of grade 2 tumor shows ER, PR positivity as compared to grade 3 tumors. Her-2/neu expression does not show any significant correlation with age or lymph node status of the patient. Conclusion: ER and PR expression in breast cancers in the current study are found to be comparable to the findings of other authors, but the frequency of HER-2/neu expression is slightly higher. Significant correlation is observed between hormonal receptor status and the grade of the tumor. Inverse relationship is found between Her-2/neu expression and ER, PR receptor status. Her-2/neu expression is increased with size and high grade of tumor.

Share and Cite:

Biswal, P. , Behera, S. , Kar, A. , Pradhan, D. , Kumar Behera, P. , Burma, S. and Mishra, C. (2015) Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases. International Journal of Clinical Medicine, 6, 961-966. doi: 10.4236/ijcm.2015.612126.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Mir, R. and Singh, V.P. (2009) Breast Cancer in Young Women and Its Impact on Reproductive Function. Apollo Medicine, 6, 200-208.
[2] (2009) Breast Cancer: Breast Cancer in Young Women. WebMD.
[3] Naeem, M., Nasir, A., Aman, Z., Ahmad, T. and Samad, A. (2008) Frequency of Her 2/Neu Positivity and Its Association with Other Features of Breast Cancer. J Ayub Med Coll, 20, 23-26.
[4] Munjal, K., Ambaye, A., Vans, M.F.E., et al. (2009) IHC Analysis of ER, PR and Her 2 Neu in Infiltrative Breast Carcinoma. Asian Pacific Journal of Cancer Prevention, 10, 773-778.
[5] Azizun-Nisa et al. (2008) Comparision of ER, PR & Her 2 Neu Status in Breast Cancer. Asian Pacific Journal of Cancer Prevention, 9, 553-556.
[6] Moses, A., Ghosh, M., et al. (2011) IHC Profile of Breast Cancer Patients at a Tertiary Care Hospital in South India. Asia Pacific Journal of cancer Prevention, 12, 625-629.
[7] Rashed, M.M., et al. (2007) The Association of Her 2 Neu over Expression in Relation to p53 Neuclear Accumulation, Hormonal Receptor Status & Clinic-Pathological Correlation in a Series of Egyptian Women with Invasive Ductal Carcinoma. European Journal of General Medicine, 4, 73-79.
[8] Antalio, A.A. and Eugler, J.M. (2009) Breast Cancer Subtype Based on ER/PR and Her 2 Neu Expression. Clinical Medicine Research, 7, 4-13.
[9] Sheet, T., Atin, A., et al. (2009) Hormone Receptor Status over last 8 Years in a Cancer Referral Centre in India; What Was and It Is. Indian Journal of Pathology and Microbiology, 52, 171-174.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.